Nivalis Therapeutics (NVLS)

Add to Watchlists
Create an Alert
4.18 -0.01  -0.24% NASDAQ May 2, 21:56 Delayed 2m USD
View Full Chart
NVLS Price Chart
View All Performance Charts

NVLS Total Returns Comparison

Advertisement

One Page Reports

Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • URL: http://www.n30pharma.com
  • Investor Relations URL: http://ir.nivalis.com/
  • HQ Country: United States
  • HQ State/Province: Colorado
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2016
  • Est. Current Fiscal Year End: December 31, 2016
  • Last Fiscal Quarter End: September 30, 2015
  • Last Fiscal Year End: December 31, 2014
  • Next Earnings Release: N/A
  • NAICS Name: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry Name: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector Name: Manufacturing
  • Profile: Nivalis Therapeutics Inc is engaged in developing small molecule therapeutics for the treatment of diseases such as cystic fibrosis, asthma, chronic obstructive pulmonary disease, inflammatory bowel disease and certain cardiovascular disorders.

NVLS Comparables

Edit

NVLS Excel Add-In Codes

  • Name: =YCI("NVLS","name")
  • Description: =YCI("NVLS","description")
  • Sector: =YCI("NVLS","sector")
  • Industry: =YCI("NVLS","industry")
  • Est. Current Fiscal Year End: =YCI("NVLS","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.